Search results
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: AstraZeneca’s plan to reach $80 billion in sales by 2030 relies heavily on a slate of...
AstraZeneca taps more China-derived tech with $19M cancer deal for Nona antibodies
Endpoints News· 2 days agoAstraZeneca on Thursday inked a license and option deal with the US offshoot of a Chinese-Dutch...
AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion Why Is ...
Benzinga· 4 days agoTuesday, AstraZeneca Plc AZN announced its ambitious plan to increase its total revenue to $80...
From In-House at AstraZeneca to an E-Discovery Startup: New Fileread GC Discusses Major Career Move...
Law.com· 5 days agoThe latest: E-discovery startup Fileread, which announced in early May that it hired the head of...
AstraZeneca (LON:AZN) Rating Reiterated by JPMorgan Chase & Co.
ETF DAILY NEWS· 2 days agoAstraZeneca (LON:AZN – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research report issued to ...
Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 3 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks· 5 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
AstraZeneca earmarks $1.5B for end-to-end ADC factory in Singapore
Endpoints News· 5 days agoAstraZeneca said on Monday morning it is building a new antibody-drug conjugate facility in...
AstraZeneca to build $1.5 bln cancer drug facility in Singapore
Medical Xpress· 5 days agoBritish pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant...
AstraZeneca aims for $80 bln in total revenue by 2030
Reuters· 4 days ago, opens new tab aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday,...